Correlation Between Adial Pharmaceuticals and Bio Path

Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adial Pharmaceuticals and Bio Path Holdings, you can compare the effects of market volatilities on Adial Pharmaceuticals and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Bio Path.

Diversification Opportunities for Adial Pharmaceuticals and Bio Path

0.32

Correlation Coefficient

Adial Pharmaceuticals  Bio Path

Weak diversification

The 3 months correlation between Adial and Bio is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Bio Path go up and down completely randomly.

Pair Corralation between Adial Pharmaceuticals and Bio Path

Given the investment horizon of 90 days Adial Pharmaceuticals is expected to generate 0.32 times more return on investment than Bio Path. However, Adial Pharmaceuticals is 3.14 times less risky than Bio Path. It trades about -0.15 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.19 per unit of risk. If you would invest  108.00  in Adial Pharmaceuticals on December 5, 2024 and sell it today you would lose (33.00) from holding Adial Pharmaceuticals or give up 30.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	84.62%
Values	Daily Returns

Adial Pharmaceuticals  vs.  Bio Path Holdings

Adial Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adial Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Bio Path Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Bio Path is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Adial Pharmaceuticals and Bio Path

The main advantage of trading using opposite Adial Pharmaceuticals and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.

The idea behind Adial Pharmaceuticals and Bio Path Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.